|
Diabetes, Vol 45, Issue 3 361-366, Copyright © 1996 by American Diabetes Association
Effects of beraprost sodium and insulin on the electroretinogram, nerve conduction, and nerve blood flow in rats with streptozotocin-induced diabetes
N Hotta, N Koh, F Sakakibara, J Nakamura, Y Hamada, T Hara, K Mori, E Nakashima, K Naruse, H Fukasawa, H Kakuta and N Sakamoto
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.
The effect of a prostacyclin analog, beraprost sodium, on the
electroretinogram, motor nerve conduction velocity, and nerve blood flow
was determined in rats with streptozotocin-induced diabetes and was
compared with the effect of insulin. Beraprost sodium (0.01 mg x kg-1 x
day-1 for 8 weeks) significantly shortened the peak latency of the
electroretinogram b-wave, increased tail nerve conduction velocity, and
increased sciatic nerve blood flow in diabetic rats (P < 0.0003, 0.0001,
and 0.0001 vs. untreated diabetic rats, respectively). This was accompanied
by a significant increase in the 6-keto-prostaglandin F1alpha content of
the thoracic aorta and a marked increase in the cAMP content of the sciatic
nerve. Beraprost sodium had no effect on the sorbitol and fructose contents
of the sciatic nerve and retina, but insulin (8-10 U/day) significantly
reduced both parameters. These findings suggest that beraprost sodium may
be useful for prevention of vascular and neural dysfunction in the retina
and peripheral nerve.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Shibata, K. Naruse, H. Kamiya, M. Kozakae, M. Kondo, Y. Yasuda, N. Nakamura, K. Ota, T. Tosaki, T. Matsuki, et al.
Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in Rats
Diabetes,
November 1, 2008;
57(11):
3099 - 3107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Naruse, Y. Hamada, E. Nakashima, K. Kato, R. Mizubayashi, H. Kamiya, Y. Yuzawa, S. Matsuo, T. Murohara, T. Matsubara, et al.
Therapeutic Neovascularization Using Cord Blood-Derived Endothelial Progenitor Cells for Diabetic Neuropathy
Diabetes,
June 1, 2005;
54(6):
1823 - 1828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. OBROSOVA, C. VAN HUYSEN, L. FATHALLAH, X. CAO, M. J. STEVENS, and D. A. GREENE
Evaluation of {alpha}1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense
FASEB J,
August 1, 2000;
14(11):
1548 - 1558.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Hotta, J. Nakamura, F. Sakakibara, Y. Hamada, T. Hara, K. Mori, E. Nakashima, H. Sasaki, N. Kasama, S. Inukai, et al.
Electroretinogram in sucrose-fed diabetic rats treated with an aldose reductase inhibitor or an anticoagulant
Am J Physiol Endocrinol Metab,
November 1, 1997;
273(5):
E965 - E971.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Diabetes Association.
|
|
| |
|